Additionally, the high cost of GLP-1 drugs, which can range between $900 and $1,350 per month, presents an affordability barrier, although it simultaneously motivates the search for more cost-effective dietary supplements
Across the trials, the drugs were linked to reductions in binge eating severity, less disinhibited eating (where people struggle to resist food despite not being physically hungry), and fewer episodes of feeling out of control while eating
DSIP has been studied for its potential association with delta wave modulation and sleep cycle regulation
tirzepatide activates both GIP and GLP-1 receptors
The takeaway isnt that these medications should be avoided, but rather that being aware of potential cutaneous effects can help clinicians recognize medication-related skin changes quicker and manage them appropriately.